Quadrant Capital Group’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-11,013
| Closed | -$443K | – | 1661 |
|
|
2025
Q1 | $443K | Buy |
11,013
+7,330
| +199% | +$295K | 0.02% | 821 |
|
|
2024
Q4 | $173K | Buy |
3,683
+31
| +0.8% | +$1.46K | 0.01% | 763 |
|
|
2024
Q3 | $193K | Buy |
3,652
+271
| +8% | +$14.3K | 0.01% | 716 |
|
|
2024
Q2 | $183K | Sell |
3,381
-668
| -16% | -$36.2K | 0.01% | 695 |
|
|
2024
Q1 | $284K | Buy |
4,049
+781
| +24% | +$54.8K | 0.02% | 489 |
|
|
2023
Q4 | $273K | Buy |
3,268
+287
| +10% | +$24K | 0.02% | 478 |
|
|
2023
Q3 | $87.8K | Buy |
2,981
+1,330
| +81% | +$39.2K | 0.01% | 952 |
|
|
2023
Q2 | $53.9K | Buy |
1,651
+147
| +10% | +$4.8K | 0.01% | 1222 |
|
|
2023
Q1 | $52.9K | Sell |
1,504
-628
| -29% | -$22.1K | 0.01% | 1205 |
|
|
2022
Q4 | $97.7K | Buy |
2,132
+173
| +9% | +$7.93K | 0.01% | 784 |
|
|
2022
Q3 | $95K | Buy |
1,959
+1,596
| +440% | +$77.4K | 0.01% | 719 |
|
|
2022
Q2 | $14K | Buy |
363
+233
| +179% | +$8.99K | ﹤0.01% | 1467 |
|
|
2022
Q1 | $5K | Buy |
130
+63
| +94% | +$2.42K | ﹤0.01% | 1899 |
|
|
2021
Q4 | $3K | Hold |
67
| – | – | ﹤0.01% | 2017 |
|
|
2021
Q3 | $2K | Buy |
67
+10
| +18% | +$299 | ﹤0.01% | 2119 |
|
|
2021
Q2 | $1K | Hold |
57
| – | – | ﹤0.01% | 2240 |
|
|
2021
Q1 | $1K | Hold |
57
| – | – | ﹤0.01% | 2198 |
|
|
2020
Q4 | $1K | Sell |
57
-6
| -10% | -$105 | ﹤0.01% | 2083 |
|
|
2020
Q3 | $1K | Buy |
63
+6
| +11% | +$95 | ﹤0.01% | 1946 |
|
|
2020
Q2 | $1K | Buy |
+57
| New | +$1K | ﹤0.01% | 2029 |
|